A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Carcinoma, Pancreatic Ductal
  • GPI-Linked Proteins
  • Mucin-1
  • Survivors
  • Tissue Array Analysis

abstract

  • NCT01647828.

publication date

  • September 2019

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC6718621

Digital Object Identifier (DOI)

  • 10.1002/cam4.2425

PubMed ID

  • 31347292

Additional Document Info

start page

  • 5148

end page

  • 5157

volume

  • 8

number

  • 11